Analysts at BNP Paribas Exane downgraded their ratings on three major oil companies due to an expected further decline in ...

Exxon Mobil (NYSE:XOM) -0.3% in Wednesday's trading as BNP Paribas Exane downgrades shares to Underperform from Neutral with ...

Fintel reports that on October 9, 2024, Exane BNP Paribas downgraded their outlook for Exxon Mobil (NYSE:XOM) from Neutral to ...

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 12.88% ...

Fintel reports that on October 1, 2024, Exane BNP Paribas initiated coverage of NextEra Energy Partners, LP - Limited Partnership (NYSE:NEP) with a Underperform recommendation. As of September 25 ...

Investing.com -- Micron Technology (NASDAQ:MU) saw its shares fall over 4% Thursday after a double downgrade from Exane BNP Paribas (OTC:BNPQY). The firm lowered its rating on Micron from ...

Hermes International is a way for investors to shield themselves from a short-term downturn in the luxury-goods sector, according to BNP Paribas Exane analysts, who upgraded the Birkin bag maker ...

(Bloomberg) -- Deutsche Post AG shares got their first sell-equivalent rating in six months as BNP Paribas Exane said analysts may need to slash earnings estimates for the German logistics group.

On Monday, BNP Paribas (OTC:BNPQY) Exane reaffirmed its Neutral stance on Carvana Co. (NYSE:NYSE:CVNA) shares, maintaining the stock's price target at $126.00. The decision follows a review of the ...

Exane BNP Paribas (OTC:BNPQY) has upgraded shares of luxury goods company Hermes International (OTC:HESAF) from Neutral to Outperform, maintaining a price target of €2,340.00. The firm ...

On Monday, BNP Paribas (OTC:BNPQY) Exane reaffirmed its Neutral stance on Carvana Co. (NYSE:NYSE:CVNA) shares, maintaining the stock's price target at $126.00. The decision follows a review of the ...